Geode Capital Management’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $60.1M | Sell |
|
|||||
|
2024
Q1 | $79.2M | Buy |
|
|||||
|
2023
Q4 | $75.9M | Buy |
|
|||||
|
2023
Q3 | $31.4M | Buy |
|
|||||
|
2023
Q2 | $42.8M | Buy |
|
|||||
|
2023
Q1 | $30.7M | Buy |
|
|||||
|
2022
Q4 | $38M | Buy |
|
|||||
|
2022
Q3 | $32.1M | Buy |
|
|||||
|
2022
Q2 | $27.8M | Buy |
|
|||||
|
2022
Q1 | $32.4M | Sell |
|
|||||
|
2021
Q4 | $30.1M | Buy |
|
|||||
|
2021
Q3 | $26.8M | Buy |
|
|||||
|
2021
Q2 | $19.3M | Buy |
|
|||||
|
2021
Q1 | $6.09M | Sell |
|
|||||
|
2020
Q4 | $7.61M | Buy |
|